BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 14754889)

  • 1. Squalestatin cures prion-infected neurons and protects against prion neurotoxicity.
    Bate C; Salmona M; Diomede L; Williams A
    J Biol Chem; 2004 Apr; 279(15):14983-90. PubMed ID: 14754889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Squalestatin alters the intracellular trafficking of a neurotoxic prion peptide.
    Wilson R; Bate C; Boshuizen R; Williams A; Brewer J
    BMC Neurosci; 2007 Nov; 8():99. PubMed ID: 18034899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Docosahexaenoic and eicosapentaenoic acids increase prion formation in neuronal cells.
    Bate C; Tayebi M; Diomede L; Salmona M; Williams A
    BMC Biol; 2008 Sep; 6():39. PubMed ID: 18789130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phospholipase A2 inhibitors or platelet-activating factor antagonists prevent prion replication.
    Bate C; Reid S; Williams A
    J Biol Chem; 2004 Aug; 279(35):36405-11. PubMed ID: 15210691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glimepiride reduces the expression of PrPc, prevents PrPSc formation and protects against prion mediated neurotoxicity in cell lines.
    Bate C; Tayebi M; Diomede L; Salmona M; Williams A
    PLoS One; 2009 Dec; 4(12):e8221. PubMed ID: 20011040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sialic Acid on the Glycosylphosphatidylinositol Anchor Regulates PrP-mediated Cell Signaling and Prion Formation.
    Bate C; Nolan W; Williams A
    J Biol Chem; 2016 Jan; 291(1):160-70. PubMed ID: 26553874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycosylphosphatidylinositol anchor analogues sequester cholesterol and reduce prion formation.
    Bate C; Tayebi M; Williams A
    J Biol Chem; 2010 Jul; 285(29):22017-26. PubMed ID: 20427265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of glycosylphosphatidylinositols in the activation of phospholipase A2 and the neurotoxicity of prions.
    Bate C; Williams A
    J Gen Virol; 2004 Dec; 85(Pt 12):3797-3804. PubMed ID: 15557253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoacylated cellular prion protein modifies cell membranes, inhibits cell signaling, and reduces prion formation.
    Bate C; Williams A
    J Biol Chem; 2011 Mar; 286(11):8752-8. PubMed ID: 21212283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of rafts in the fibrillization and aggregation of prions.
    Pinheiro TJ
    Chem Phys Lipids; 2006 Jun; 141(1-2):66-71. PubMed ID: 16647049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequestration of free cholesterol in cell membranes by prions correlates with cytoplasmic phospholipase A2 activation.
    Bate C; Tayebi M; Williams A
    BMC Biol; 2008 Feb; 6():8. PubMed ID: 18269734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PrP Knockout Cells Expressing Transmembrane PrP Resist Prion Infection.
    Marshall KE; Hughson A; Vascellari S; Priola SA; Sakudo A; Onodera T; Baron GS
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27847358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mouse prion protein (PrP) segment 100 to 104 regulates conversion of PrP(C) to PrP(Sc) in prion-infected neuroblastoma cells.
    Hara H; Okemoto-Nakamura Y; Shinkai-Ouchi F; Hanada K; Yamakawa Y; Hagiwara K
    J Virol; 2012 May; 86(10):5626-36. PubMed ID: 22398286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prion protein and lipid rafts.
    Taylor DR; Hooper NM
    Mol Membr Biol; 2006; 23(1):89-99. PubMed ID: 16611584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying key components of the PrPC-PrPSc replicative interface.
    Abalos GC; Cruite JT; Bellon A; Hemmers S; Akagi J; Mastrianni JA; Williamson RA; Solforosi L
    J Biol Chem; 2008 Dec; 283(49):34021-8. PubMed ID: 18826953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Squalestatin protects neurons and reduces the activation of cytoplasmic phospholipase A2 by Abeta(1-42).
    Bate C; Williams A
    Neuropharmacology; 2007 Aug; 53(2):222-31. PubMed ID: 17583757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of lipid rafts in prion protein biology.
    Lewis V; Hooper NM
    Front Biosci (Landmark Ed); 2011 Jan; 16(1):151-68. PubMed ID: 21196164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The charge structure of helix 1 in the prion protein regulates conversion to pathogenic PrPSc.
    Norstrom EM; Mastrianni JA
    J Virol; 2006 Sep; 80(17):8521-9. PubMed ID: 16912302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prion protein accumulation in lipid rafts of mouse aging brain.
    Agostini F; Dotti CG; Pérez-Cañamás A; Ledesma MD; Benetti F; Legname G
    PLoS One; 2013; 8(9):e74244. PubMed ID: 24040215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prion peptide 106-126 as a model for prion replication and neurotoxicity.
    Singh N; Gu Y; Bose S; Kalepu S; Mishra RS; Verghese S
    Front Biosci; 2002 Apr; 7():a60-71. PubMed ID: 11897566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.